Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lowe

Showing results (141-150 of 321) with videos related to

Pageof 33
Sort By:
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2007
Role of the chromobox protein CBX7 in lymphomagenesisClare L Scott, Jésus Gil, Eva Hernando, et al.
Cancer Research|June 7, 2018
The Canonical Wnt Pathway Drives Macropinocytosis in CancerGil Redelman-Sidi, Anna Binyamin, Isabella Gaeta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
Cancer|June 25, 2009
Yes-associated protein is an independent prognostic marker in hepatocellular carcinomaMichelle Z Xu, Tzy-Jyun Yao, Nikki P Y Lee, et al.
Nature|June 25, 2015
Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Nature Genetics|June 19, 2007
Tissue-specific and reversible RNA interference in transgenic miceRoss A Dickins, Katherine McJunkin, Eva Hernando, et al.
Genes & Development|December 7, 2007
Dissecting eIF4E action in tumorigenesisHans-Guido Wendel, Ricardo L A Silva, Abba Malina, et al.
Nature|October 23, 2014
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Nature|June 10, 2005
A microRNA polycistron as a potential human oncogeneLin He, J Michael Thomson, Michael T Hemann, et al.
Pageof 33

Showing results (141-150 of 321) with videos related to

Sort By:
Pageof 33
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2007
Role of the chromobox protein CBX7 in lymphomagenesisClare L Scott, Jésus Gil, Eva Hernando, et al.
Cancer Research|June 7, 2018
The Canonical Wnt Pathway Drives Macropinocytosis in CancerGil Redelman-Sidi, Anna Binyamin, Isabella Gaeta, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteinsMonika A Davare, Anna Saborowski, Christopher A Eide, et al.
Cancer|June 25, 2009
Yes-associated protein is an independent prognostic marker in hepatocellular carcinomaMichelle Z Xu, Tzy-Jyun Yao, Nikki P Y Lee, et al.
Nature|June 25, 2015
Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Nature Genetics|June 19, 2007
Tissue-specific and reversible RNA interference in transgenic miceRoss A Dickins, Katherine McJunkin, Eva Hernando, et al.
Genes & Development|December 7, 2007
Dissecting eIF4E action in tumorigenesisHans-Guido Wendel, Ricardo L A Silva, Abba Malina, et al.
Nature|October 23, 2014
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 systemDanilo Maddalo, Eusebio Manchado, Carla P Concepcion, et al.
Nature|June 10, 2005
A microRNA polycistron as a potential human oncogeneLin He, J Michael Thomson, Michael T Hemann, et al.
Pageof 33